Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Empower Increases Revenue & Patient Visits, Reduces Expenses

Stockhouse Editorial
0 Comments| November 7, 2019

{{labelSign}}  Favorites
{{errorMessage}}

CBD life sciences Company Empower Clinics Inc. (CSE: CBDT, OTCQB: EPWCF, Forum) released its Q3 2019 preliminary unaudited financial report on Thursday. The Company highlighted year-over-year revenue growth of roughly 138% and total direct clinic expenses reduced by around 40%. The number of patients has also been increasing, with 1,847 visits in October 2019, a 336% jump from October 2018 with 550 patients.

For a closer look at this report, click here.

CBDT recently announced a joint venturewith Heritage Cannabis to produce hemp-derived CBD oils and formulated products in Oregon, USA.

FULL DISCLOSURE: Empower Clinics Inc. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company